BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24051694)

  • 1. Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.
    Liu TC; Vachharajani N; Chapman WC; Brunt EM
    Mod Pathol; 2014 Mar; 27(3):420-32. PubMed ID: 24051694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
    Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
    Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
    Larson BK; Guindi M
    Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.
    Evason KJ; Grenert JP; Ferrell LD; Kakar S
    Hum Pathol; 2013 May; 44(5):750-8. PubMed ID: 23084586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular tumours in noncirrhotic liver tissue].
    Goltz D; Fischer HP
    Pathologe; 2015 Nov; 36(6):597-606; quiz 607-8. PubMed ID: 26496997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
    Cho SJ; Ferrell LD; Gill RM
    Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.
    Hechtman JF; Raoufi M; Fiel MI; Taouli B; Facciuto M; Schiano TD; Blouin AG; Thung SN
    Am J Surg Pathol; 2011 Jun; 35(6):927-32. PubMed ID: 21572265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
    Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
    Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
    Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P
    J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor.
    Sasaki M; Yoneda N; Kitamura S; Sato Y; Nakanuma Y
    Mod Pathol; 2012 Dec; 25(12):1584-93. PubMed ID: 22766792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype.
    Huang WC; Liau JY; Jeng YM; Liu KL; Lin CN; Song HL; Tsai JH
    J Gastroenterol Hepatol; 2020 Apr; 35(4):680-688. PubMed ID: 31698521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant transformation of hepatocellular adenoma in men].
    Goudard Y; Rouquie D; Bertocchi C; Daligand H; Baton O; Lahutte M; Terris B; Baranger B
    Gastroenterol Clin Biol; 2010 Mar; 34(3):168-70. PubMed ID: 20189337
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma in a liver-cell adenoma within a non-cirrhotic liver.
    Burri E; Steuerwald M; Cathomas G; Mentha G; Majno P; Rubbia-Brandt L; Meier R
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):437-41. PubMed ID: 16538118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
    Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
    Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of hepatic adenomas.
    Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
    Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma arising in a telangiectatic hepatocellular adenoma.
    González-Lara MF; Córdova-Ramón JC; Gamboa-Domínguez A; Cosme-Labarthe J; Carrillo-Pérez DL
    Ann Hepatol; 2013; 12(4):626-8. PubMed ID: 23813141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male.
    Kim DH; Kim SU; Nam DH; Choi YJ; Park SM; Lee CK; Kim DY
    Korean J Intern Med; 2009 Jun; 24(2):147-52. PubMed ID: 19543495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Liver Biopsies with Well-Differentiated Hepatocellular Lesions.
    Umetsu SE; Kakar S
    Surg Pathol Clin; 2023 Sep; 16(3):581-598. PubMed ID: 37536890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant transformation of hepatocellular adenoma: report of a case.
    Mouhoub M; Miry A; Haloui A; Karich N; Kamaoui I; Soufi M; Bennani A
    Pan Afr Med J; 2020; 35():92. PubMed ID: 32636990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population.
    Liu HP; Zhao Q; Jin GZ; Qian YW; Gu YJ; Dong H; Lu XY; Cong WM; Wu MC
    Pathol Res Pract; 2015 Dec; 211(12):918-24. PubMed ID: 26608415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.